Results 151 to 160 of about 73,788 (259)
ABSTRACT Background Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) is assessed by cell counting and cytomorphology from cerebrospinal fluid (CSF) and is used for treatment stratification worldwide. The ratio of “CNS2” patients in clinical trials ranges from 3% to 40%, with unclear prognostic significance ...
Laura Almási +14 more
wiley +1 more source
Abstract Vascular cognitive impairment (VCI), the second leading cause of dementia, is characterized by heterogeneous pathophysiology and a potentially reversible early phase, underscoring the need for timely identification. This review synthesizes advances across four complementary domains – targeted cognitive assessments, imaging biomarkers ...
Wenqi Song +8 more
wiley +1 more source
Incidence and Risk Factors of Post-Lumbar Puncture Headache in Patients With Cognitive Impairment. [PDF]
Wang X +6 more
europepmc +1 more source
Engagement of understudied populations as community change: The South Texas ADRC model
Abstract Many populations experiencing the highest burdens of Alzheimer's disease and related dementias remain understudied, in part because traditional recruitment and retention models are insufficient to support sustained engagement. The Outreach, Recruitment, and Engagement Core (OREC) of the South Texas Alzheimer's Disease Research Center ...
Gladys E. Maestre +34 more
wiley +1 more source
Subdural Hematoma After Lumbar Puncture in Patients with Coagulation Disorders: A Case Report and Pathogenetic Implications. [PDF]
Ding C +5 more
europepmc +1 more source
CSF fibrinogen predicts longitudinal Tau accumulation in cognitively unimpaired older adults
Abstract INTRODUCTION Blood–brain barrier (BBB) dysfunction is an early feature of Alzheimer's disease (AD). Fibrinogen represents a sensitive marker of BBB leakage, but whether it modifies longitudinal tau progression in cognitively unimpaired (CU) individuals remains unknown.
Christos Panagiotis Lisgaras +21 more
wiley +1 more source
Safe platelet count for lumbar puncture: are we being overcautious? [PDF]
Badar T.
europepmc +1 more source
Abstract INTRODUCTION ABvac40 is an active immunotherapy targeting Aβ40, the main component of cerebrovascular deposition in Alzheimer's disease (AD). A 24‐month randomized, placebo‐controlled phase 2 study (Part A) showed favorable safety and robust immunogenicity, with exploratory signals of clinical efficacy.
María Pascual‐Lucas +15 more
wiley +1 more source
Multicentre study of the role of lumbar puncture in the diagnosis of spontaneous subarachnoid haemorrhage. [PDF]
Thompson D +7 more
europepmc +1 more source
Objective Accurately predicting future hemorrhagic events in patients with cerebral amyloid angiopathy (CAA) remains a major clinical challenge. It is unknown whether cerebrospinal fluid (CSF) biomarkers of amyloid‐beta (Aβ) pathology are associated with increased hemorrhage risk in this population.
Philipp Arndt +15 more
wiley +1 more source

